Sign in

CIK 0001464521 · Non-accelerated filer<br>Emerging growth company

Heartflow, Inc.

Sign in to watch
Ticker
HTFL
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
260506743
Phone
650-241-1221
Business address
135 MAIN STREET, SUITE 1000, SAN FRANCISCO, CA, 94105
Former names
Cardiovascular Simulation, Inc.
  1. 4 Shares withheld for taxes Chief Financial Officer gave up 542 shares (to pay taxes)
  2. 4 Planned sale Director sold 8,000 shares at $27.32 ($218,560)
  3. 4 Open-market sale 10% owner sold 2,000,000 shares at $28.05 ($56,100,000)
  4. 4 Open-market buy Director bought 40,000 shares at $26.34 ($1,053,680)
  5. 4 Shares withheld for taxes Chief Medical Officer gave up 439 shares (to pay taxes)
  6. 4 Shares withheld for taxes Chief Executive Officer gave up 1,339 shares (to pay taxes)
  7. 4 Shares withheld for taxes Chief Financial Officer gave up 471 shares (to pay taxes)
  8. 4 Shares withheld for taxes Chief Accounting Officer, VP gave up 81 shares (to pay taxes)
  9. 4 Conversion 10% owner acquired 6,697,556 shares (conversion)
  10. 3 Insider Initial Statement of Ownership
  11. 4 Conversion 10% owner acquired 12,448,158 shares (conversion)
  12. 4 Derivatives Options or other derivatives
  13. 4 Conversion Director acquired 136,286 shares (conversion)
  14. 4 Derivatives Options or other derivatives
  15. 4 Grant or award Chief Executive Officer acquired 59,868 shares (grant or award)
  16. 4 Grant or award Chief Financial Officer acquired 21,052 shares (grant or award)
  17. 4 Grant or award Chief Medical Officer acquired 21,052 shares (grant or award)
  18. 4 Grant or award Chief Accounting Officer, VP acquired 3,618 shares (grant or award)
  19. 4 Conversion Director acquired 131,578 shares (conversion)
  20. 4 Conversion Director acquired 3,187,509 shares (conversion)

Page 4 of 5 · 93 filings